Myriad's BRCA Gene Patents Struck Down In Court; Are Biotech's Foundations Shaking?

Judge finds that isolated DNA is not different from that in the body and thus unpatentable; Myriad says its products are covered by other patents.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet